Jason Silvers
Vermogen: 26 240 $ op 31-05-2026
Vermogen: 26 240 $ op 31-05-2026
Jason Silvers is currently President & Chief Financial Officer at Generate Biomedicines, Inc., a position starting in 2026.
Formerly, Dr. Silvers was Managing Director at Goldman Sachs & Co. LLC from 2002 to 2022.
Education includes undergraduate studies at Brown University, a doctorate from The Johns Hopkins University School of Medicine, and graduate studies at Yale Law School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-03-2026 | 2.000 ( 0% ) | 26 240 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| GENERATE BIOMEDICINES, INC. | Financieel Directeur/CFO | 01-07-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01-06-2022 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale Law School
Yale Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Operates as a clinical-stage generative biology company that provides biotechnology and drug design & development services | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau